ModernaMRNA
Moderna on podcasts: where it advertises, what it's offering listeners, and what hosts say about it when they're not being paid.
Sponsorships
No ad reads on tracked podcasts in the last 30 days. Hosts are talking about it anyway — see the earned side.
What hosts are saying
Most mentioned on
In their words
“So, ticker MRNA. So, pairing a little bit of the opening gains up now just 1.9%. It was up over 2% uh closer to the open earlier. So, Cityroup analyst Jeffrey Meechum apparently recommending to sell the stock and it has rallied more than 500% this year. So, that is a massive rally and city's analysts saying that crude valuations are quote unjustifiable after that big gain.”
Citi analyst recommends selling after 600% rally, citing unjustifiable valuations despite positive cancer vaccine trial data
▶ Hear it“MODERNA SHARES FALLING THE MOST IN A MONTH AS A CITIGROUP ANALYST RECOMMENDED SELLING THE STOCK, SAYING ITS CURRENT VALUATION IS 'UNJUSTIFIABLE' FOLLOWING A RALLY.”
Analyst recommended selling stock due to unjustifiable valuation, shares fell 5% following rally.
▶ Hear it“What do you think when you saw Madna gain more than any other stock has ever gained in a major index in one day? Like what was your reaction to that? >> It makes sense. I mean these if if what they've done and and what what seems to be uh approved is uh is what we think it is a vaccine against cancer that's unbelievable.”
Praised for developing a vaccine against cancer and gaining more than any other stock has ever gained in a major index in one day.
▶ Hear itThe full picture
A weekly email with where each one advertised and what hosts said about them. Free.